In vivo osteogenic durability of cultured bone in porous ceramics - A novel method for autogenous bone graft substitution

被引:94
作者
Yoshikawa, T [1 ]
Ohgushi, H
Nakajima, H
Yamada, E
Ichijima, K
Tamai, S
Ohta, T
机构
[1] Nara Med Univ, Dept Pathol 1, Kashihara, Nara 6348521, Japan
[2] Nara Med Univ, Dept Orthoped Surg, Kashihara, Nara 6348521, Japan
[3] Teijin Inst Biomed Res, Pharmacol Res Dept, Hino, Tokyo 1918512, Japan
关键词
D O I
10.1097/00007890-200001150-00022
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Bone marrow cells differentiate into bone-forming osteoblasts when cultured in medium supplemented with 15% fetal bovine serum, ascorbic acid, beta-glycerophosphate, and dexamethasone, Methods. To investigate in vivo osteoblastic activity and bone matrix formation by cultured bone marrow cells, Fischer rat marrow cells were cultured for 2 weeks in porous hydroxyapatite (HA) and then subcutaneously implanted into 7-week-old male syngeneic rats, The implants were harvested after 8 and 52 weeks for biochemical and histological analyses. Results. At both times, formation of lamellar bone accompanied by regeneration of marrow were seen in many of the HA pores, When a fluorochrome (calcein) was administered at 50 weeks after implantation, it was detected in the pores of implants harvested at 52 weeks. Osteoclastic resorption follows by new bone formation was seen in some pores at 82 weeks, indicating that bone remodeling was continuing. The alkaline phosphatase activity of implants harvested at; 52 weeks was comparable to that at 8 weeks, whereas the osteocalcin content of the implants harvested at 62 weeks was about twice that at 8 weeks. Conclusion, These results demonstrated that there was persistent in vivo osteogenic and hematopoietic activity in the prefabricated bone/HA constructs, and indicated that normal bone tissue was regenerated after grafting of the constructs, which were brittle before implantation. Tissue engineering using HA and cultured marrow cells culture may provide an alternative method of bone transplantation for patients with skeletal disorders, although further in vivo and in vitro experiments are needed.
引用
收藏
页码:128 / 134
页数:7
相关论文
共 42 条
  • [1] LacZ and interleukin-3 expression in vivo after retroviral transduction of marrow-derived human osteogenic mesenchymal progenitors
    Allay, JA
    Dennis, JE
    Haynesworth, SE
    Majumdar, MK
    Clapp, DW
    Shultz, LD
    Caplan, AI
    Gerson, SL
    [J]. HUMAN GENE THERAPY, 1997, 8 (12) : 1417 - 1427
  • [2] Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO
  • [3] 2-F
  • [4] Monoclonal antibodies reactive with human osteogenic cell surface antigens
    Bruder, SP
    Horowitz, MC
    Mosca, JD
    Haynesworth, SE
    [J]. BONE, 1997, 21 (03) : 225 - 235
  • [5] DAVIES JE, 1991, CELL MATER, V1, P3
  • [6] DAVIES JE, 1991, BONE-BIOMATERIAL INTERFACE, P214
  • [7] THE BONE TITANIUM INTERFACE INVITRO
    DAVIES, JE
    LOWENBERG, B
    SHIGA, A
    [J]. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1990, 24 (10): : 1289 - 1306
  • [8] DEBOER HH, 1988, CLIN ORTHOP RELAT R, P292
  • [9] FUJIWARA K, 1981, CANCER RES, V41, P4121
  • [10] GOSHIMA J, 1991, CLIN ORTHOP RELAT R, P274